SDB-005
id:
sdb-005-309-11293958
title:
SDB-005
text:
SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analog of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group. The code number SDB-005 was originally used for a different compound, the N-phenyl instead of N-benzyl analogue of SDB-006. This compound is a potent agonist of the CB1 receptor (Ki = 21 nM) and CB2 recepto
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/SDB-005
date created:
date modified:
2022-09-07T15:36:19Z
main entity:
{"identifier":"Q21098933","url":"https://www.wikidata.org/entity/Q21098933"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/d5/SDB-005_structure.png","width":348,"height":456}
fields total:
13
integrity:
15